SCHEMBL28990797

SCHEMBL28990797

COCCC[C@H](OC(N)=O)c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.37
CASP1 P29466 1/20 0.36
P2RX7 Q99572 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AOC3 Q16853 1/20 0.35
ATM Q13315 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRL1 P41146 1/20 0.35
AVPR2 P30518 1/20 0.35
AVPR1A P37288 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28990639 1.00 HPGD (0.37) HPGDCASP1P2RX7TSHRL3MBTL1
SCHEMBL28990667 0.92 CASP1 (0.38) HPGDCASP1P2RX7TSHRAOC3
SCHEMBL28990632 0.92 CASP1 (0.38) HPGDCASP1P2RX7TSHRAOC3
SCHEMBL28990782 0.90 AVPR2 (0.35) CASP1L3MBTL1AOC3ATMOPRM1
SCHEMBL28990727 0.90 AVPR2 (0.35) CASP1L3MBTL1AOC3ATMOPRM1
SCHEMBL28990608 0.86 CASP1 (0.40) HPGDCASP1P2RX7TSHRL3MBTL1
SCHEMBL28990789 0.85 HPGD (0.40) HPGDP2RX7TSHRALDH1A1GLA
SCHEMBL28990701 0.85 MAPT (0.37) CASP1AOC3AVPR2AVPR1A
SCHEMBL28990747 0.85 MAPT (0.37) CASP1AOC3AVPR2AVPR1A
SCHEMBL28990596 0.84 AVPR2 (0.35) CASP1P2RX7AOC3ATMAVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111419830-B Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epileptic related syndromes 比皮艾思药物研发有限公司 2024-01-30 CN disclosed
CN-115996905-A Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases 生物药品解决方案有限公司 2023-04-21 CN disclosed